2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
9459
Neoplasms
6577
Prostatic Neoplasms
4394
Colorectal Neoplasms
3964
Lung Neoplasms
3633
Carcinoma, Non-Small-Cell Lung
3576
Pancreatic Neoplasms
2472
Carcinoma, Hepatocellular
2407
Leukemia, Myeloid, Acute
2261
Multiple Myeloma
2115
Stomach Neoplasms
2104
Neoplasm Metastasis
1911
Head and Neck Neoplasms
1864
Ovarian Neoplasms
1770
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1732
Lymphoma
1728
Brain Neoplasms
1696
Rectal Neoplasms
1672
Melanoma
1652
Colonic Neoplasms
1629
Leukemia
1498
Uterine Cervical Neoplasms
1493
Recurrence
1480
Esophageal Neoplasms
1309
Glioblastoma
1303
Lymphoma, Non-Hodgkin
1202
Leukemia, Lymphocytic, Chronic, B-Cell
1120
Squamous Cell Carcinoma of Head and Neck
1108
Urinary Bladder Neoplasms
1077
Lymphoma, Follicular
1067
Interventions
sintilimab
1
nedaplatin
1
Pemetrexed
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Advanced Non-squamous Non-Small-Cell Lung Cancer
×
Clear all
NCT05648071
2022-12-13
SPBPDC
Qianfoshan Hospital
Phase 3
Unknown
60 enrolled